Brinker, L., Sideris, K., Wei, G., Singh, R., Nevers, M. R., Hartsell, S. E., … Stehlik, J. (2025). Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis. JACC. Heart Failure, 13(8), 102520. https://doi.org/10.1016/j.jchf.2025.102520

Brinker, Lina, Konstantinos Sideris, Guo Wei, Ravinder Singh, McKenna R. Nevers, Sydney E. Hartsell, Amara Sarwal, et al. “Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis.” JACC. Heart Failure 13, no. 8 (August 2025): 102520. https://doi.org/10.1016/j.jchf.2025.102520.

Brinker L, Sideris K, Wei G, Singh R, Nevers MR, Hartsell SE, et al. Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis. JACC Heart failure. 2025 Aug;13(8):102520.

Brinker, Lina, et al. “Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis.” JACC. Heart Failure, vol. 13, no. 8, Aug. 2025, p. 102520. Epmc, doi:10.1016/j.jchf.2025.102520.

Brinker L, Sideris K, Wei G, Singh R, Nevers MR, Hartsell SE, Sarwal A, Kyriakopoulos CP, Tseliou E, Benes J, Melenovsky V, Drakos SG, Hanff TC, Carter S, Fang JC, Cho M, Beddhu S, Stehlik J. Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis. JACC Heart failure. 2025 Aug;13(8):102520.